NO20006699D0 - Forbindelser med veksthormonfrigjörende egenskaper - Google Patents

Forbindelser med veksthormonfrigjörende egenskaper

Info

Publication number
NO20006699D0
NO20006699D0 NO20006699A NO20006699A NO20006699D0 NO 20006699 D0 NO20006699 D0 NO 20006699D0 NO 20006699 A NO20006699 A NO 20006699A NO 20006699 A NO20006699 A NO 20006699A NO 20006699 D0 NO20006699 D0 NO 20006699D0
Authority
NO
Norway
Prior art keywords
growth hormone
compounds
hormone releasing
releasing properties
properties
Prior art date
Application number
NO20006699A
Other languages
English (en)
Other versions
NO331351B1 (no
NO20006699L (no
Inventor
Bernd Peschke
Stefan Lutz Ichter
Thomas Kruse Hansen
Michael Ankersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20006699D0 publication Critical patent/NO20006699D0/no
Publication of NO20006699L publication Critical patent/NO20006699L/no
Publication of NO331351B1 publication Critical patent/NO331351B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
NO20006699A 1998-06-30 2000-12-29 Forbindelser med veksthormonfrigjorende egenskaper NO331351B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199800857 1998-06-30
DKPA199801440 1998-11-09
PCT/DK1999/000368 WO2000001726A1 (en) 1998-06-30 1999-06-29 Compounds with growth hormone releasing properties

Publications (3)

Publication Number Publication Date
NO20006699D0 true NO20006699D0 (no) 2000-12-29
NO20006699L NO20006699L (no) 2001-02-28
NO331351B1 NO331351B1 (no) 2011-12-05

Family

ID=26064788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006699A NO331351B1 (no) 1998-06-30 2000-12-29 Forbindelser med veksthormonfrigjorende egenskaper

Country Status (20)

Country Link
EP (1) EP1100824B1 (no)
JP (1) JP4511040B2 (no)
KR (1) KR100907638B1 (no)
CN (1) CN1304424C (no)
AT (1) ATE500269T1 (no)
AU (1) AU771644B2 (no)
BR (1) BRPI9911756B1 (no)
CA (1) CA2334315C (no)
CY (1) CY1111509T1 (no)
CZ (1) CZ299648B6 (no)
DE (1) DE69943239D1 (no)
DK (1) DK1100824T3 (no)
HU (1) HUP0102460A3 (no)
IL (1) IL140044A0 (no)
NO (1) NO331351B1 (no)
PL (1) PL199853B1 (no)
PT (1) PT1100824E (no)
RU (1) RU2298547C2 (no)
TW (1) TW593337B (no)
WO (1) WO2000001726A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2462200A1 (en) * 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
KR20070010151A (ko) * 2004-03-30 2007-01-22 사파이어 세라퓨틱스, 인크. 성장 호르몬 분비촉진제를 이용하여 ｃ-반응성 단백질을감소시키는 방법
KR101380200B1 (ko) 2004-08-12 2014-04-01 헬신 세라퓨틱스 (유.에스.) 인크. 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을촉진하는 방법
US7772177B2 (en) 2005-05-18 2010-08-10 Aegera Therapeutics, Inc. BIR domain binding compounds
WO2007048224A1 (en) 2005-10-25 2007-05-03 Aegera Therapeutics Inc. Iap bir domain binding compounds
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
KR20090107088A (ko) 2007-02-09 2009-10-12 트랜자임 파르마 인크 거대고리 그렐린 수용체 조절제 및 이의 사용 방법
CN107382827B (zh) * 2017-04-14 2021-01-01 江苏普莱医药生物技术有限公司 氨基酸衍生物或其药学上可接受的盐及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924506A1 (de) * 1989-07-25 1991-01-31 Hoechst Ag Renin-hemmende aminooligohydroxy-derivate
NZ258412A (en) * 1992-12-11 1997-01-29 Merck & Co Inc Spiro-fused piperidine derivatives and pharmaceutical compositions
BR9608909A (pt) * 1995-06-22 1999-03-02 Novo Nordisk As Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto
WO1997023508A1 (en) * 1995-12-22 1997-07-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
WO1998003473A1 (en) * 1996-07-22 1998-01-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
WO1998058950A1 (en) * 1997-06-20 1998-12-30 Novo Nordisk A/S Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
EP1100824B1 (en) 2011-03-02
NO331351B1 (no) 2011-12-05
PL345204A1 (en) 2001-12-03
DK1100824T3 (da) 2011-06-20
CZ299648B6 (cs) 2008-10-01
TW593337B (en) 2004-06-21
EP1100824A1 (en) 2001-05-23
BR9911756A (pt) 2001-04-03
KR20010053310A (ko) 2001-06-25
NO20006699L (no) 2001-02-28
AU771644B2 (en) 2004-04-01
CN1307588A (zh) 2001-08-08
CA2334315C (en) 2011-07-26
IL140044A0 (en) 2002-02-10
PT1100824E (pt) 2011-06-16
KR100907638B1 (ko) 2009-07-14
HUP0102460A2 (hu) 2001-11-28
HUP0102460A3 (en) 2001-12-28
WO2000001726A1 (en) 2000-01-13
BRPI9911756B1 (pt) 2016-06-14
AU4603899A (en) 2000-01-24
CN1304424C (zh) 2007-03-14
CZ20004565A3 (en) 2001-06-13
ATE500269T1 (de) 2011-03-15
JP4511040B2 (ja) 2010-07-28
PL199853B1 (pl) 2008-11-28
RU2298547C2 (ru) 2007-05-10
CY1111509T1 (el) 2015-08-05
CA2334315A1 (en) 2000-01-13
JP2002519436A (ja) 2002-07-02
DE69943239D1 (de) 2011-04-14

Similar Documents

Publication Publication Date Title
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
ZA979961B (en) 5-HT1F agonists
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
YU13301A (sh) Muskarinski agonisti i antagonisti
SE9802937D0 (sv) Novel compounds
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
TR200200278T2 (tr) Kalsilitik bileşimler
ID25478A (id) Agonis 5-ht1f
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
NO20012169L (no) Forbindelser med veksthormonfrigjörende egenskaper
NO20003629D0 (no) Forbindelser med veksthormonfrigjørende egenskaper
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь
UA42301A (uk) Засіб "камілаль" для лікування і профілактики проктологічних захворювань

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: HELSINN HEALTHCARE SA, CH

MM1K Lapsed by not paying the annual fees